The study addresses the limitations of current definitions, which have often been adapted from adult smoking metrics without considering how these definitions’ relevance might be affected by the unique patterns and lower risk profiles of e-cigarettes.
“The examples of countries like New Zealand and Australia, geographically close but vastly different in terms of shared public policies, provide a clear picture of the global situation regarding the implementation of harm reduction policies for smoking. While Australia, committed to restrictive policies on reduced-risk products, is forced to backtrack on its positions, New Zealand, by promoting combustion-free devices as effective tools for tackling smoking, has halved the smoking rate, almost eradicating the problem,” explained Professor Polosa.
In this prestigious setting, CoEHAR had the opportunity to present the latest results of its intense research activities. The Italian research center is today recognized as one of the most prolific and authoritative center in the field of the research applied to harm reduction strategies. In this context, two leading experts in the medical and legal fields presented an overview of the international situation regarding the policies for combustion-free products, with a particular focus on Australia and New Zealand.
The appointment is scheduled for Tuesday, June 25th, at 3:30 PM, in the Caduti di Nassirya room, Palazzo Madama.
Researchers from the CoEHAR at the University of Catania, together with international experts from the DiaSmokeFree Working Group, aimed to answer these questions: what could be the effects of smoking cessation on the efficacy and safety of antidiabetic drugs? Could significant changes occur that would require a readjustment of pharmacological treatments?
Among the numerous panels of experts from around the world who gathered to share data and future perspectives, experts and researchers from CoEHAR shared significant updates on the activities of the Catania research center conducted over the past year.
Present at the event, Jeffrey Zamora, President of ASOVAPE Costa Rica and Project Leader of the Veritas project, a research conducted by CoEHAR which will try to identify if there are any harmful effects of long-term regular vaping on respiratory health or other endpoints for people who never smoked.
Dr. Emma, researcher at the Replica project, is going to present: "Replica Project: A Journey Through Multicentric Research Endeavors". The appointment is set for June 14 at 11,30 am.
Thanks to additional funding from the PNRR Heal Italia, CoEHAR researchers are initiating further collaboration with the Universities of Bari and Palermo for the Diasmoke project.
Resident doctors, PhD students, young researchers, and masters students coordinated the CoEHAR annual meeting dedicated to the World No Tobacco Day 2024, sharing experiences from their own social contexts, including…
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.